Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.

BACKGROUND AND METHODS Treatment with methylprednisolone and chlorambucil may protect renal function and increase the chance of remission of the nephrotic syndrome in patients with idiopathic membranous nephropathy. To determine whether similar results might be obtained with methylprednisolone alone, we compared the effects of methylprednisolone and chlorambucil with those of methylprednisolone alone in 92 patients with the nephrotic syndrome caused by idiopathic membranous nephropathy. The patients were randomly assigned to receive either alternating one-month courses of methylprednisolone and then chlorambucil for a total of six months (group 1) or methylprednisolone alone for six months at the same cumulative dosage (group 2). RESULTS Four of the 45 patients in group 1 (9 percent) and 1 of the 47 in group 2 (2 percent) stopped treatment because of side effects. At one, two, and three years, the percentage of patients who did not have the nephrotic syndrome was significantly higher in group 1 than in group 2. It was 58, 54, and 66 percent, respectively, in group 1, as compared with 26, 32, and 40 percent in group 2 (P = 0.002, 0.029, and 0.011). By year 4, the difference was no longer statistically significant: 62 percent of the patients in group 1 and 42 percent of those in group 2 did not have the nephrotic syndrome (P = 0.102). The patients in group 1 were in remission longer than those in group 2 (P = 0.008). CONCLUSIONS In patients with the nephrotic syndrome caused by idiopathic membranous nephropathy, treatment with methylprednisolone and chlorambucil for six months induces an earlier remission of the nephrotic syndrome than methylprednisolone alone, but the difference may diminish with time.

[1]  L. Hunt,et al.  Prognostic indicators in patients presenting with the nephrotic syndrome. , 1988, Kidney international.

[2]  C. Cardella,et al.  A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. , 1989, The New England journal of medicine.

[3]  C. Ponticelli,et al.  A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy , 1984 .

[4]  R. Wilkinson,et al.  The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. , 1984, Clinical nephrology.

[5]  R. Mactier,et al.  The natural history of membranous nephropathy in the West of Scotland. , 1986, The Quarterly journal of medicine.

[6]  G. Neild,et al.  The long-term outcome of idiopathic membranous nephropathy. , 1981, Clinical nephrology.

[7]  J. Velosa,et al.  Idiopathic membranous nephropathy: the natural history of untreated patients. , 1988, Kidney international.

[8]  S. Adler,et al.  Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. , 1991, Annals of internal medicine.

[9]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[10]  C. Alpers,et al.  Neoplasia and glomerular injury. , 1986, Kidney international.

[11]  K. Konishi,et al.  Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. , 1989, American journal of nephrology.

[12]  S. Geisser,et al.  An Extension of Box's Results on the Use of the $F$ Distribution in Multivariate Analysis , 1958 .

[13]  C. Ohlschlegel,et al.  Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. , 1989, Clinical nephrology.

[14]  K. Jindal,et al.  A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. , 1987, Kidney international.

[15]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[16]  W. Suki,et al.  Membranous nephropathy: response to steroids and immunosuppression. , 1981, American journal of nephrology.

[17]  C. Greenwood,et al.  Prednisone in the treatment of idiopathic membranous nephropathy. , 1989, The New England journal of medicine.

[18]  J. Churg,et al.  Treatment of idiopathic membranous nephropathy. , 1976, The New England journal of medicine.

[19]  J. Eagen,et al.  Glomerulopathies of neoplasia. , 1977, Kidney international.

[20]  P. S. Williams,et al.  Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  C. Ponticelli,et al.  Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  A. Rees,et al.  PREDNISOLONE AND CHLORAMBUCIL TREATMENT IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH DETERIORATING RENAL FUNCTION , 1988, The Lancet.

[23]  C. Ponticelli,et al.  Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.